Sample Technologies
Search documents
Qiagen Q4 Earnings Call Highlights
Yahoo Finance· 2026-02-07 04:07
Qiagen logo Key Points Qiagen beat its outlook for 2025, reporting full-year net sales of $2.09 billion (+5% CER) and adjusted EPS of $2.40, with Q4 net sales of $540 million (+1% CER) and adjusted EPS of $0.62. The company’s five “growth pillars” generated $1.49 billion in 2025 (up 8% CER) — led by QIAstat‑Dx, QuantiFERON, QIAcuity, Sample Technologies and QDI — and management says this keeps Qiagen on track for at least $2 billion of combined growth‑pillar sales by 2028, aided by the Parse Bioscienc ...
QIAGEN(QGEN) - 2025 Q4 - Earnings Call Transcript
2026-02-05 15:32
Qiagen (NYSE:QGEN) Q4 2025 Earnings call February 05, 2026 09:30 AM ET Company ParticipantsDaniel Wendorff - VP and Head of Investor RelationsRoland Sackers - CFOThierry Bernard - CEOConference Call ParticipantsAisyah Noor - AnalystCasey Woodring - AnalystDan Brennan - AnalystDoug Schenkel - AnalystHarry Gillis - AnalystJack Meehan - AnalystKavya Deshpande - AnalystMichael Ryskin - AnalystOdysseas Manesiotis - AnalystTycho Peterson - AnalystOperatorLadies and gentlemen, thank you for standing by. I am Katie ...
QIAGEN(QGEN) - 2025 Q4 - Earnings Call Transcript
2026-02-05 15:30
Qiagen (NYSE:QGEN) Q4 2025 Earnings call February 05, 2026 09:30 AM ET Speaker7Ladies and gentlemen, thank you for standing by. I am Katie, your call operator. Welcome, and thank you for joining QIAGEN's fourth quarter 2025 earnings conference call webcast. At this time, all participants are in listen-only mode. Please be advised this call is being recorded at QIAGEN's request and will be made available on their internet site. The prepared remarks will be followed by a question-and-answer session. If you wo ...
Qiagen N.V. (QGEN) Deep Dive Into Sample Technologies: Leadership, Innovation and Future Expansion Transcript
Seeking Alpha· 2025-11-21 18:33
Core Insights - QIAGEN's Sample Technologies business is fundamental to molecular testing, focusing on the preparation of samples to extract DNA and RNA, which is essential for all molecular workflows [1][3] - The company emphasizes its unmatched leadership in Sample Technologies and its commitment to expanding this leadership through automation, high-value applications, and new technologies [1] Challenges and Innovations - Preparing samples presents significant challenges, which QIAGEN addresses through its innovative approaches and technologies [3] - The company is poised to lead the next wave of innovation in the Sample Technologies field, indicating a strong focus on future advancements [3]